Pacific-Link Consulting   Report issue

For profit Phase 2
Founded: San Diego CA United States (2010)

Organization Overview

First Clinical Trial
2011
NCT01379209
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Pacific-Link Regulatory Consulting LLC

Active Ingredients

Drugs in Phase 2 Trials (2)

ad-reic/dkk-3 (1 trial)

krn-7000 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Graft vs Host Disease (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2